BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6837286)

  • 1. Hyperthermia increases aminoglycoside ototoxicity.
    Henry KR; Guess MB; Chole RA
    Acta Otolaryngol; 1983; 95(3-4):323-7. PubMed ID: 6837286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of cochlear damage in kanamycin administered hamster and protective effect of cepharanthine against KM induced ototoxicity. An experimental study].
    Akisada T
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Aug; 90(8):1229-44. PubMed ID: 3681541
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat.
    Wu WJ; Sha SH; McLaren JD; Kawamoto K; Raphael Y; Schacht J
    Hear Res; 2001 Aug; 158(1-2):165-78. PubMed ID: 11506949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss.
    Sha SH; Zajic G; Epstein CJ; Schacht J
    Audiol Neurootol; 2001; 6(3):117-23. PubMed ID: 11474137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between cochlear hair cell loss and shifts of masked and absolute behavioral auditory thresholds in the house mouse.
    Ehret G
    Acta Otolaryngol; 1979; 87(1-2):28-38. PubMed ID: 760375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individual variation and mechanism of kanamycin ototoxicity in rabbits (author's transl)].
    Ohtani I; Ohtsuki K; Aikawa T; Takenaka M; Omata T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Feb; 84(2):121-8. PubMed ID: 7277078
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian rhythm dependent kanamycin-induced hearing loss in rodents assessed by auditory brainstem responses.
    Yonovitz A; Fisch JE
    Acta Otolaryngol; 1991; 111(6):1006-12. PubMed ID: 1763620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
    Murillo-Cuesta S; Contreras J; Cediel R; Varela-Nieto I
    Lab Anim; 2010 Apr; 44(2):124-31. PubMed ID: 19858169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histopathologic study on nephrotoxocity of tuberactinomycin-N, with special reference to interrelation between nephrotoxicity and ototoxicity (author's transl)].
    Akiyoshi M; Yoshizawa M; Hayano K
    Kekkaku; 1974 Jul; 49(7):217-23. PubMed ID: 4139301
    [No Abstract]   [Full Text] [Related]  

  • 10. Ototoxicity of kanamycin in albino and pigmented guinea pigs. I. A morphologic and electrophysiologic study.
    Wästerström SA; Bredberg G; Lindquist NG; Lyttkens L; Rask-Anderson H
    Am J Otol; 1986 Jan; 7(1):11-8. PubMed ID: 3946575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of the antiapoptotic TAT-FNK protein prevents aminoglycoside-induced ototoxicity.
    Kashio A; Sakamoto T; Kakigi A; Suzuki M; Suzukawa K; Kondo K; Sato Y; Asoh S; Ohta S; Yamasoba T
    Gene Ther; 2012 Dec; 19(12):1141-9. PubMed ID: 22189415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug toxicity of the inner ear.
    Hybels RL
    Med Clin North Am; 1979 Mar; 63(2):309-19. PubMed ID: 86663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protective effect of fosfomycin against aminoglycoside induced ototoxicity].
    Ohtsuki K; Ohtani I; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1983 Dec; 86(12):1487-96. PubMed ID: 6674446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study on ototoxicity of cisplatin].
    Qie WX
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):195-8, 254. PubMed ID: 2076320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory effect of kanamycin given to newborn guinea pigs whose mothers received kanamycin during pregnancy.
    Wang Z; Liou L
    Ann Otol Rhinol Laryngol; 1994 Dec; 103(12):983-5. PubMed ID: 7993011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural cochlear changes following acoustic hyperstimulation and ototoxicity.
    Lim DJ
    Ann Otol Rhinol Laryngol; 1976; 85(6 PT. 1):740-51. PubMed ID: 999139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of cochlear and vestibular functions of patients treated by dibekacin in an E.N.T. unit].
    Uziel A; Goubert JL
    Nouv Presse Med; 1982 Nov; 11(46):3456-8. PubMed ID: 6984174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ototoxicity on the auditory brain stem response and the scalp-recorded cochlear microphonic in guinea pigs.
    Schwent VL; Williston JS; Jewett DL
    Laryngoscope; 1980 Aug; 90(8 Pt 1):1350-9. PubMed ID: 7401837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of superior semicircular canal dehiscence.
    Minor LB
    Laryngoscope; 2005 Oct; 115(10):1717-27. PubMed ID: 16222184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the intrauterine ototoxicity of dibekacin].
    Uziel A; Marot M
    Nouv Presse Med; 1982 Nov; 11(46):3432-4. PubMed ID: 7155852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.